Home | Cancers | Prostate Cancer

Prostate Cancer

Men with prostate cancer and depression have lower survival rates than those who aren't depressed

UCLA study finds patients are often diagnosed later, receive less effective therapies and don't live as long ...

Study finds diagnosing physicians influence treatment decisions for prostate cancer patients

Wide variations seen in up-front therapy versus active surveillance ...

Prostate cancer care worse for Māori and rural men

Statistics show that Māori men are faring poorly for prostate cancer diagnosis and treatment. ... Full story

Vasectomy may increase risk of aggressive prostate cancer

Boston, MA — Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer according to a new study from Harvard School of Public Health (HSPH). ... Full story

Prostate cancer study praised

Health Minister, Tony Ryall has praised a report from a three year $900,000 University of Auckland study into prostate cancer care. ... Full story

Guidelines Address Long-Term Needs of Prostate Cancer Survivors

Recommendations to Support Primary Care of Estimated 2.8 Million Men with History of Prostate Cancer in the U.S. ... Full story

Prostate cancer biomarkers identified in seminal fluid

Improved diagnosis and management of one of the most common cancers in men - prostate cancer - could result from research at the University of Adelaide, which has discovered that seminal fluid (semen) contains biomarkers for the disease. ... Full story

HEALTH LINE: Active Surveillance for Prostate Cancer Could Be Better Option

CINCINNATI—It’s often a medical dilemma: treat or don’t treat (meaning watch the condition closely and treat at the most opportune time). ... Full story

Prostate cancer testing is on trial

The University of Sydney's School of Public Health is seeking people to participate in a "community jury" to independently asses the process of Prostate Specific Antigen (PSA) testing in Australia. ... Full story

Prostate cancer drug delivers benefits before chemotherapy

By Duke Medicine News and Communications - DURHAM, N.C. -- A drug currently used to treat men with late-stage prostate cancer proved effective in stemming disease progression and extending survival in patients who had not yet received chemotherapy, according to results from a large international study that included Duke Cancer Institute researchers. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 122 | displaying: 1 - 10